Results 21 to 30 of about 44 (35)

Cognitive impairment in patients with type 2 diabetes mellitus: prevalence, pathogenetic mechanisms, the effect of antidiabetic drugs [PDF]

open access: yes, 2018
In recent years, a large amount of data has been accumulated on the relationship between cognitive impairment, dementia and diabetes mellitus. This article presents an overview of modern literature, including the definition of cognitive functions, the ...
Ekaterina V. Rebrova   +4 more
core   +2 more sources

Pharmacoeconomic analysis of modern oral hypoglycemic agents with inadequate glycemic control on metformin [PDF]

open access: yes, 2019
The aim. Based on a pharmacoeconomic analysis (PHe) of the use of sodium-glucose cotransporter-2 inhibitors (iSGLT2) and dipeptidyl peptidase-4 (iDPP-4) inhibitors to determine the optimal treatment strategy in patients with type 2 diabetes mellitus ...
A. E. Cheberda   +3 more
core   +2 more sources

ǂThe ǂinfluence os Sneznik mineral water on microbiota, metabolic, biochemical and anthropometric parameters in patients with type 2 diabetes mellitus [PDF]

open access: yes, 2023
Uvod: s obzirom da je mineralna vode sa izvora „Snežnik-1/79“ još od početka 20. veka bila prepoznata za lečenje problema gastrointestinalnog trakta, glavna hipoteza ove studije je bila da njena upotreba može doprineti u otklanjanju konstipacije kod ...
Jovičić, Nikola B.
core  

Standards of specialized diabetes care. Edited by Dedov I.I., Shestakova M.V., Mayorov A.Yu. 9th edition [PDF]

open access: yes, 2019
Dear Colleagues! We are glad to present the 9th Edition (revised) of Standards of Diabetes Care. These evidence-based guidelines were designed to standardize and facilitate diabetes care in all regions of the Russian Federation. The Standards are updated
Aleksandr Y. Mayorov   +30 more
core   +2 more sources

Analysis of effectiveness criteria in pharmacoeconomic studies of hypoglycemic drugs proposed for inclusion into the essential drug list in 2014-2016 in Russia [PDF]

open access: yes, 2018
Rationale. There is a certain variability of endpoints in diabetes pharmacoeconomic research in Russia. It makes difficult to compare the economical effectiveness of hypoglycemic drugs. Aim.
A. A. Kurylev   +2 more
core   +1 more source

Конгресс Европейского общества кардиологов (Лондон, 2015): результаты важнейших клинических исследований [PDF]

open access: yes, 2015
Представлен отчет о всех шести научных сессиях Hot Line Конгресса Европейского общества кардиологов 2015 г., посвященных острому инфаркту миокарда, фибрилляции предсердий / электрокардиостимуляции, сахарному диабету / фармакотерапии, артериальной ...
Канорский, С.Г.
core  

[Synergistic effects of GABA and hypoglycemic drugs]. [PDF]

open access: yesProbl Endokrinol (Mosk), 2023
Tyurenkov IN   +2 more
europepmc   +1 more source

учебное пособие для студентов медвузов и клинических ординаторов [PDF]

open access: yes, 2017
В учебно-методическом пособии представлена современная классификация хронической болезни почек, дана характеристика ее стадий, описаны факторы прогрессирования.
Голивец, Т. П.   +4 more
core  

[Characteristics of purchases of hypoglycemic agents in pharmacy retail sector in 2016-2020 years dynamics]. [PDF]

open access: yesProbl Endokrinol (Mosk), 2023
Kurkin DV   +7 more
europepmc   +1 more source

[Summary of the 2023 European Society of Cardiology clinical guidelines on the management of cardiovascular disease in patients with diabetes mellitus]. [PDF]

open access: yesProbl Endokrinol (Mosk)
Erlikh AD   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy